Drug-drug interactions of antibiotics and psychotropic medication

被引:0
|
作者
Joos, AAB [1 ]
机构
[1] Univ Ulm, Zentrum Psychiat Weissenau, D-89069 Ulm, Germany
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
By and large, pharmacokinetic interactions are described: macrolide antibiotics, isoniazid, ciprofloxacin and ampicillin can lead to toxic concentrations of psychotropic drugs, while rifampicin causes subtherapeutic levels. Vice versa, carbamazepine might induce subtherapeutic plasma concentrations of doxycycline. These interactions are caused by inhibition or induction of the hepatic cytochrome P450 enzyme system. Case reports suggest lithium intoxication through concomitant use of tetracycline, metronidazol and spectinomycin, which is contradicted by animal studies. Clinical symptoms depend on the therapeutic index of a given drug, e.g. toxic and subtherapeutic levels are described for clozapine but not for haloperidol. No relevant pharmacodynamic drug-drug interactions are described, although, the author emphasises psychiatric side effects of macrolide antibiotics, isoniazid, beta-lactam antibiotics and fluoroquinolones. On the whole, drug-drug interactions of antibiotics and psychotropics seem rare and usually benign, though more subtle interactions might be overlooked.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [1] An overview of psychotropic drug-drug interactions
    Sandson, NB
    Armstrong, SC
    Cozza, KL
    PSYCHOSOMATICS, 2005, 46 (05) : 464 - 494
  • [2] DRUG-DRUG INTERACTIONS WITH THE USE OF PSYCHOTROPIC MEDICATIONS
    Sloan, Diane M.
    Ereshefsky, Larry
    CNS SPECTRUMS, 2009, 14 (08) : 1 - 8
  • [3] Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: Evaluation of a paired approach for psychotropic medication
    GexFabry, M
    BalantGorgia, AE
    Balant, LP
    THERAPEUTIC DRUG MONITORING, 1997, 19 (01) : 1 - 10
  • [4] ADVERSE DRUG INTERACTIONS WITH PSYCHOTROPIC MEDICATION
    TAYLOR, WJR
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1974, 10 (02) : 156 - 156
  • [5] Drug-drug interactions between psychotropic medications and oral contraceptives
    Schoretsanitis, Georgios
    Deligiannidis, Kristina M.
    Paulzen, Michael
    Spina, Edoardo
    de Leon, Jose
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (06) : 395 - 411
  • [6] Psychotropic Drug-Drug Interactions Involving P-Glycoprotein
    Akamine, Yumiko
    Yasui-Furukori, Norio
    Ieiri, Ichiro
    Uno, Tsukasa
    CNS DRUGS, 2012, 26 (11) : 959 - 973
  • [7] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    Brett A. English
    Marcus Dortch
    Larry Ereshefsky
    Stanford Jhee
    Current Psychiatry Reports, 2012, 14 : 376 - 390
  • [8] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    English, Brett A.
    Dortch, Marcus
    Ereshefsky, Larry
    Jhee, Stanford
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (04) : 376 - 390
  • [9] Psychotropic Drug-Drug Interactions in Three Most Commonly Used Drug Information Databases
    Liu, Xinyue
    Barnicoat, Marie
    Bussing, Regina
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 452 - 453
  • [10] Drug-drug interactions between COVID-19 therapeutics and psychotropic medications
    Cuomo, Alessandro
    Barilla, Giovanni
    Serafini, Gianluca
    Aguglia, Andrea
    Amerio, Andrea
    Cattolico, Matteo
    Carmellini, Pietro
    Spiti, Alessandro
    Fagiolini, Andrea
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (12) : 925 - 936